Stay updated on Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 to the page history; removed HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T12:47:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added and the previous revision v3.3.1 was removed from the history; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:21.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T14:39:47.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The notice about government funding and operating status was removed from the page, an administrative change that does not affect trial data or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:48:18.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The screenshots show only minor UI differences with no substantive changes to core trial data (e.g., status, eligibility, or location details). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T01:14:08.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Introducing a government funding lapse notice and an updated software version (v3.2.0); removing the previous version tag (v3.1.0).
    Difference
    8%
    Check dated 2025-10-05T10:07:08.000Z thumbnail image

Stay in the know with updates to Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Plus Trastuzumab in HER2+ Colorectal Cancer Clinical Trial page.